Use of anti-prolactin agents to treat proliferative conditions

Details Use of anti-prolactin agents to treat proliferative conditions Use of anti-prolactin agents to treat proliferative conditions

A - Human Necessities

61

K

A61K 38/22 (2006.01) A61K 31/138 (2006.01) A61K 38/27 (2006.01) A61P 35/00 (2006.01) C07K 14/72 (2006.01) C12Q 1/02 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2328520

The present invention relates to variant forms of human prolactin which act as antagonists at the prolactin receptor, and to the use of such variants in the treatment of human cancers and proliferative disorders, including both begnin and malignant diseases of the breast and prostate.

L'invention concerne des variantes de la prolactine humaine qui agissent comme antagonistes au niveau du récepteur de la prolactine. L'invention concerne également l'utilisation de ces variantes pour le traitement de cancers humains et de troubles prolifératifs, y compris des affections, tant bénignes que malignes, du sein et de la prostate.

Affiliated with

Also associated with

Rating

Use of anti-prolactin agents to treat proliferative conditions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of anti-prolactin agents to treat proliferative conditions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of anti-prolactin agents to treat proliferative conditions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1972849